Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy

Anne Schmechtig, Jane Lees, Lois Grayson, Kevin J Craig, Rukiya Dadhiwala, Gerard R Dawson, J F William Deakin, Colin T Dourish, Ivan Koychev, Katrina McMullen, Ellen M Migo, Charlotte Perry, Lawrence Wilkinson, Robin Morris, Steve C R Williams, Ulrich Ettinger

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

The increasing demand to develop more efficient compounds to treat cognitive impairments in schizophrenia has led to the development of experimental model systems. One such model system combines the study of surrogate populations expressing high levels of schizotypy with oculomotor biomarkers.
Original languageEnglish
Pages (from-to)331-45
Number of pages15
JournalPsychopharmacology
Volume227
Issue number2
DOIs
Publication statusPublished - May 2013

Fingerprint

Dive into the research topics of 'Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy'. Together they form a unique fingerprint.

Cite this